2-[[(TETRAHYDROPYRAN-2-YL)OXY]METHYL]BENZYL ALCOHOL, 97.0%, 5g

(2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile, 98%, 1g

4-(4-Aminophenyl)piperazine-1-carboxylic acid tert-butyl ester, 98.00%, 100g

4-(Pyridin-2-yl)morpholine, 95.0%, 5g

2-Chloro-3-fluorobenzotrifluoride, 95.0%, 1g

1,1,1-Trimethoxypentane, 97.0%, 5g

N,N-Dimethyl-1H-pyrazole-1-sulfonamide, 95.0%, 25g

Benzyl 2-bromoethyl ether, 97.0%, 500g

2-(tert-Butoxycarbonyl)-5-oxa-2,6-diazaspiro[3.4]oct-6-ene-7-carboxylic acid, 98+%, 250mg

(S,E)-ethyl 2,5-dimethyl-4-(methylamino)hex-2-enoate hydrochloride, 95%, 100mg

2-Amino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid ethyl ester, 98.0%, 100g

Tétraborate de disodium décahydraté, min 99,5 %, pa, ACS, ISO, 2,5 kg, emballage plastique.

EMD 387008 (R-IMEGLIMIN) HCL, 95.0%, 10mg